Aptiva Medical has officially completed its acquisition of VeraMed Health, enhancing its position as a leader in the distribution of continuous glucose monitoring (CGM) systems. This strategic move, announced on October 7, 2025, not only expands Aptiva’s patient base but also strengthens its referral and payor networks across the United States.
The acquisition is set to accelerate Aptiva Medical’s growth trajectory, reinforcing its commitment to providing advanced diabetes management solutions. With a focus on direct-to-patient services, the integration of VeraMed’s operations is expected to improve patient care and streamline service delivery.
Strengthening Leadership in Diabetes Management
David Wallace, Co-Founder and Managing Partner of Greenleaf Ventures, highlighted the significance of this acquisition. He stated, “This acquisition aligns perfectly with Aptiva Medical’s mission to build a leading, nationwide direct-to-patient CGM business.” Wallace praised the foundation of patient care established by the VeraMed team and assured that Aptiva Medical would facilitate a seamless transition for all patients, while continuing to enhance service quality.
Greenleaf Ventures, based in Fort Lauderdale, Florida, has a proven track record in the healthcare sector, having successfully built and scaled various companies, including Access Diabetic Supply and Liberty Medical. The firm specializes in investing in healthcare and medical supply companies, focusing on creating value and improving operational efficiencies.
The acquisition of VeraMed Health adds to Aptiva Medical’s already comprehensive service offerings, which include home delivery of CGMs, diabetes testing supplies, and specialty transplant medications. The company aims to provide end-to-end patient support, which encompasses everything from prescription coordination to insurance billing, making it easier for patients to manage their diabetes effectively.
Looking Ahead
This acquisition positions Aptiva Medical for continued success in a competitive market. The enhanced capabilities and expanded reach are expected to deliver improved adherence to treatment plans and better health outcomes for patients managing diabetes.
As the demand for CGM systems continues to rise, Aptiva Medical’s strategic expansion through the acquisition of VeraMed Health could set a new standard for diabetes care in the United States. The company’s commitment to innovation and patient-focused solutions remains steadfast, promising significant benefits for healthcare providers and patients alike.
For further information, Aptiva Medical can be contacted at their headquarters in Fort Lauderdale, or through their website.